IGHE and asthma: Serum IgE, which is characteristic of the asthma immune response, is known to be elevated in patients with bronchial asthma, being predictive of the development of bronchial hyperreactive allergic disease in children [44], while therapy that aimed to decrease serum IgE has been shown to be beneficial for severe disease management [45].